San Francisco Hoteliers Complete City-Wide LLS Fundraiser

The Hotel Council of San Francisco has finished up the Million Dollar Mission, its impressive summer fundraising campaign to benefit the Leukemia & Lymphoma Society (LLS), by having raised almost $400,000.

The single-industry fundraiser was a 30-day campaign conducted city-wide by 28,000 hoteliers from over 181 participating hotels.

"I commend the work of The Hotel Council of San Francisco to support the Leukemia & Lymphoma Society by raising critical funds to support cancer research," said San Francisco Mayor Ed Lee in a statement. "This campaign has brought unity among our hotels and has shown that San Francisco continues to be a city with a big heart committed to making a difference."

The campaign was lead by Tom Klein, General Manager and Regional Vice President of one of the city's oldest and most famous hotels, the Fairmont. Klein also serves as a member on the San Francisco Hotel Council Board. In 2010, Klein was named Man of the Year for the LLS.

"As the 2010 Man of the Year for LLS, I took on the role of Campaign Chair knowing that if we combined forces (as the second largest employer and greatest revenue generating industry in San Francisco), 'we' could (and would) make a difference towards finding a cure for blood cancers," said Klein.

"I want to personally thank our community partners, vendors and guests of our fine city, who supported this remarkable campaign. I am extremely proud and honored to be surrounded by so many caring, passionate and committed industry professionals. Our efforts will make a significant impact in providing much needed funds to LLS and their research programs and moving us that much closer to the cure."

Source: USPolitics

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap